Subgroup Identification Based on Quantitative Objectives
Pharmaceutical Statistics · 2025
DOI: 10.1002/pst.2455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Yan Sun und 1 weiteren Autor:innen. Beteiligte Einrichtung: AbbVie, North Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Precision Medicine, Randomized Controlled Trials as Topic, Drug Development, Research Design. Die Arbeit nennt 26 Literaturangaben. Gefördert von: United States National Science Foundation.
Abstract (Originalsprache)
Precision medicine is the future of drug development, and subgroup identification plays a critical role in achieving the goal. In this paper, we propose a powerful end‐to‐end solution squant (available on CRAN) that explores a sequence of quantitative objectives. The method converts the original study to an artificial 1:1 randomized trial, and features a flexible objective function, a stable signature with good interpretability, and an embedded false discovery rate (FDR) control. We demonstrate its performance through simulation and provide a real data example.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AbbVie, North Chicago, Illinois, USA.
- Department of Mathematics, Statistics, and Computer Science, University of Illinois, Chicago, Illinois, USA.
ORCID-Profile: Yan Sun
Förderung
- United States National Science Foundation
Zitieren
APA
Sun, Y., & Hedayat, A. S. (2025). Subgroup Identification Based on Quantitative Objectives. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2455
Vancouver
Sun Y, Hedayat AS. Subgroup Identification Based on Quantitative Objectives. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2455
BibTeX
@article{Sun2025,
author = {Sun, Yan and Hedayat, A S},
title = {Subgroup Identification Based on Quantitative Objectives},
journal = {Pharmaceutical Statistics},
year = {2025},
doi = {10.1002/pst.2455}
}
EUVIMED